Circulating Tumor Cell Dx Is Technology To Watch In 2009 – Cleveland Clinic
This article was originally published in The Gray Sheet
Executive Summary
Use of circulating tumor cell assays to predict chemotherapy success will be the most significant medical innovation to break through in 2009, a panel of Cleveland Clinic physicians predicts